X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

January 18, 2018

Paul Lammers, M.D., M.Sc. Joins Triumvira as President and Chief Executive Officer

Read the full press release here.

RELATED NEWS

Conavi Medical Corp. Announces Closing of $20M Public Offering Registration is now open for the 2025 Bloom Burton & Co. Healthcare Investor Conference! Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares Bloom Burton & Co. Announces the 2025 Bloom Burton Award Satellos Announces Closing of US$40M Public Offering Titan Announces the Closing of Conavi’s Private Placement of Subscription Receipts and Provides Update on the Transaction Roberto Bellini Receives the 2024 Bloom Burton Award Acquisition of Fusion Pharmaceuticals Completed Three Finalists Announced for the 2024 Bloom Burton Award Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader

2025 BLOOM BURTON & CO DESIGNED & DEVELOPED BY THE TEAM AT PIXELCARVE MEMBER CIRO MEMBER CIPF PRIVACY POLICY COMPLAINT BEST EXECUTION POLICY ACCESSIBILITY POLICY BUSINESS CONTINUITY PLAN LEGAL DISCLAIMER CONFLICTS OF INTEREST